CEPI
-
healthGavi Commits $50M to Combat Bundibugyo Ebola Outbreak in DRC and Uganda
Global vaccine alliance Gavi launches First Response Fund to accelerate Bundibugyo Ebola vaccine development and outbreak control.
-
healthWHO Slashes Congo Ebola Count to 116; Vaccine Race Intensifies
WHO drastically revises suspected Ebola cases in Congo down to 116, from over 1,000, as testing clarifies other diseases. Five patients recover.
-
healthCEPI Grants $61.8 Million to Accelerate Ebola Vaccine Development
CEPI awards $61.8M to Moderna, Oxford, and IAVI for rapid development of vaccines against the Bundibugyo Ebola strain.
-
healthModerna Receives $50 Million to Develop mRNA Ebola Vaccine
CEPI funds Moderna, IAVI, and Oxford to develop vaccines against the deadly Bundibugyo Ebola strain currently raging in the DRC.
-
healthGlobal Health Funders Fast-Track Three Ebola Vaccines as Outbreak Spreads in Africa
CEPI accelerates development of three Ebola vaccines as Bundibugyo virus spreads in DRC and Uganda, with up to $50 million for Moderna's mRNA candidate.
-
healthModerna Launches Phase 3 Bird Flu Vaccine Trial Amid Pandemic Concerns
Moderna's investigational mRNA-based H5 influenza vaccine, mRNA-1018, enters Phase 3 trials in the US and UK to assess pandemic preparedness.